Human metapneumovirus: insights from a ten-year molecular and epidemiological analysis in Germany

Janine Reiche1, Sonja Jacobsen1, Katrin Neubauer1

  • 1Division of Influenza Viruses and Other Respiratory Viruses, National Reference Centre for Influenza, Robert Koch Institute, Berlin, Germany.

Plos One
|February 8, 2014
PubMed

Insights

Human metapneumovirus (HMPV) causes respiratory illness in all age groups. This 10-year study reveals HMPV prevalence in children and the elderly, with seasonal peaks and diverse genetic lineages circulating in Germany.

Area of Science:

  • Virology
  • Epidemiology
  • Molecular Biology

Background:

  • Human metapneumovirus (HMPV) is a significant respiratory pathogen affecting individuals across all age groups.
  • Understanding its epidemiological and molecular diversity is crucial for public health interventions.

Purpose of the Study:

  • To investigate the epidemiological and molecular diversity of HMPV in patients of different ages over a 10-year period.
  • To analyze the prevalence, clinical features, seasonality, and genetic characteristics of HMPV in Germany.

Main Methods:

  • Detection of HMPV using a sensitive real-time RT-PCR assay in outpatient and hospitalized patient samples.
  • Epidemiological analysis of HMPV prevalence across different age groups and seasons.
  • Molecular characterization of HMPV genetic lineages and sub-clusters, including identification of novel amino acid substitutions.

Main Results:

  • HMPV was detected in 3% of outpatients with influenza-like illness and 11.9% of hospitalized children under 4 years.
  • Infections were most prevalent in young children (0-4 years) and the elderly (>60 years), with peak detection in February and March.
  • Complex cyclic patterns of HMPV subgroup A and B dominance were observed, with German HMPV representing all major genetic lineages, including co-circulation and newly emerging amino acid substitutions in lineage B2.

Conclusions:

  • This study provides novel insights into the long-term molecular epidemiology of HMPV in both inpatient and outpatient settings in Germany.
  • It highlights the significant burden of HMPV, particularly in vulnerable populations, and the dynamic nature of its genetic diversity.
  • The findings support HMPV as a key focus for European and global respiratory virus surveillance and comparative molecular analysis.

Related Concept Videos

Human Virome01:26

Human Virome

The human body harbors a vast and diverse viral community known as the human virome. The virome includes bacteriophages that infect bacteria, and eukaryotic viruses that infect human cells. Transient dietary and environmental viruses also contribute to this dynamic ecosystem. Estimates suggest the human body may contain on the order of 10¹³ viral particles, though abundance varies widely by body site and detection method.Comprehensive characterization of the virome has become possible...
47
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease...
84
Viral Mutations00:36

Viral Mutations

A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
33.0K
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
24